Search for Clinical Trial Results
Sarcoma, Synovial - 11 Studies Found
Status | Study |
Recruiting |
Study Name: DHEA in Synovial Sarcoma Patients Condition:
|
Terminated |
Study Name: First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 Condition: Sarcoma, Synovial Date: 2011-11-03 Interventions:
|
Terminated |
Study Name: A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma Condition: Synovial Sarcoma Date: 2005-08-30 Interventions: Drug: Anti-CTLA4 (monoclonal antibody MDX-010) |
Recruiting |
Study Name: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Condition: Synovial Sarcoma Date: 2011-04-26 Interventions: Biological: NY-ESO-1(c259)T Cells Cytoreductive chemotherapy followed by infusion with NY-ESO-1(c259) tr |
Recruiting |
Study Name: Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases Condition:
Date: 2014-07-02 Interventions: Radiation: Whole Lung IMRT External beam radiation therapy will be administered on an outpatient basis, |
Completed |
Study Name: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Condition: Sarcoma Date: 2005-03-03 Interventions: Biological: trastuzumab |
Completed |
Study Name: Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Condition: Sarcoma Date: 2003-01-24 Interventions: Drug: gefitinib |
Completed |
Study Name: Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma Condition:
Date: 2011-01-21 Interventions: |
Recruiting |
Study Name: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer Condition:
|
Recruiting |
Study Name: Detection of Circulating Tumor Cells in Patients With Sarcomas Condition:
|